Chemistry:1T-LSD

From HandWiki

1T-LSD, also known as 1-(thiophene-2-carbonyl)-LSD or as SYN-L-021, is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug.[1][2] It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was determined to contain 1T-LSD instead.[3] It was also detected in Germany around the same time.[4]

Use and effects

A 150 μg dose of 1T-LSD is said to be equivalent to 100 μg LSD.[2] Doses of 87 to 100 μg 1T-LSD have been encountered in blotter tabs.[1]

Interactions

Chemistry

Analogues

Analogues of 1T-LSD include ALD-52 (1A-LSD), 1P-LSD, 1B-LSD, 1V-LSD, 1DD-LSD, and 1T-AL-LAD, among others.

Society and culture

Canada

1T-LSD is not a controlled substance in Canada as of 2025.[5]

United States

1T-LSD is not an explicitly controlled substance in the United States.[6] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

References